DFX Intelligence
Venture Capital Intelligence
Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.
Firms / Pitango Healthtech
Pitango Healthtech
Institutional venture firm · probableHerzliyapitango.comSEC exempt reporting adviserpart of Pitango VC
One of 5 advisers that share pitango.com; the firm is Pitango VC. Pitango International Mc 2019 Ltd., Pitango Healthtech Mc 2022 Ltd, Pitango Venture Capital, Pitango Venture Partners 2004 Ltd.. Each keeps its own CRD, funds and filings; the grouping is the website each swore to on Form ADV and is recomputed every pass.
venture manager, reported GAV $143M across 2 vehicles
Importance
19
moderate
Active deployment
0
low
Emerging
0
low
Completeness
50
elevated
Freshness
97
high
Research priority
5
low
Identity and regulatory footprint
- Headquarters
- Herzliya, Israeladviserinfo.sec.gov
- Office address
- 11 HAMENOFIM STREET, BUILDING B, Herzliya, 4672562adviserinfo.sec.gov
- Business phone
- 972-9-9718100adviserinfo.sec.gov
- Website
- HTTP://WWW.PITANGO.COM
- SEC adviser type
- exempt reporting adviseradviserinfo.sec.gov
- SEC exemption claimed
- private fund adviseradviserinfo.sec.gov
- Latest Form ADV
- Mar 28, 2024
- Private funds reported
- 2 (2 venture capital funds)adviserinfo.sec.gov
- Private fund gross assets
- $143Madviserinfo.sec.govreported GAV of the funds, the adviser's own number; not fund size, not dry powder
- Owners on Schedule A
- A.I. Assets Capital Ltd. (Shareholder), B; A.Y.M Capital Holdings 2004 Ltd. (Shareholder), B; ROM Capital Holdings 2004 Ltd. (Shareholder), B; The Pitango LP (Shareholder), B; Petra Capital 2004 Ltd. (Shareholder), B; 6k Holdings 2004 Ltd. (Shareholder), B; Samba Properties Ltd. (Shareholder), B
- business phone
- 972-9-9718100adviserinfo.sec.govpublished by the subject
Stated thesis versus observed behaviour
no observed deals yet
Stated (the firm’s website)
- Sectors
- not stated or not yet read
- Stages
- not stated or not yet read
- Geography
- not stated
- Check size
- not stated; DFX does not estimate checks from round sizes
Observed (from deals on record)
Stage at participation: no observed deals yet
Stage at first entry: no observed deals yet
Sectors: no observed deals yet
lead rate n/afollow-on rate n/anew logos, 12 months 0
Funds and vehicles
2 reported
| Vehicle | Type | Vintage | Lifecycle | Reported GAV | Owners | Form D sold | Latest Form D |
|---|---|---|---|---|---|---|---|
| Pitango Healthtech Fund I, L.P. | Fund | 2019 form d first sale | Mature | $140M Mar 28, 2024 | 29 | $132M | May 1, 2020 |
| Pitango Healthtech Principals Fund I, L.P. | Feeder or parallel | unknown | Unknown | $3.3M Mar 28, 2024 | 9 | unknown | unknown |
GAV is the gross asset value the adviser reported on Form ADV for the vehicle, never the fund’s committed size and never dry powder. Form D sold is the amount sold as of the latest filing, never a final close.
Investment team
8 current, 1 departed
Aaron Mankovski
PartnerManaging Director · since Jan 1, 2021
Eyal Niv
PartnerShareholder/Managing Director · since Feb 1, 2018
Isaac Hillel
PartnerManaging Director · since Jan 1, 2021
Ittai Harel
PartnerShareholder/Managing Director · since Jan 1, 2021
Rami Kalish
PartnerManaging Director · since Jan 1, 2021
Zeev Binman
Platform and operationsManaging Director/Chief Financial Officer · since Jan 1, 2021
Ayal Itzkovitz
PrincipalShareholder/Director · since Feb 1, 2018
Nechemia Peres
PrincipalShareholder/Director · since Dec 1, 2016
1 departed (kept with end dates)
- GUY Ezekiel · Shareholder/Director · Feb 1, 2018 to Mar 31, 2023 Inference
Investments on record
0 edges, 0 companies, 0 partner-attributed
No investment on record yet. Edges arrive from the firm’s portfolio page, financing announcements, and Form D board seats.
Co-investors
4 relationships from shared deals, counted for the whole firm
Limited partners
0 disclosed
No LP commitment on record. An LP edge needs a public disclosure with a quote: a pension report (see Limited partners for the plans read), a fund announcement naming the LP, or a Form ADV owner. The fund page carries the LP’s reported performance.
Timeline
4 dated events
- Mar 31, 2023GUY Ezekiel (Shareholder/Director) no longer on Schedule A of Pitango Healthtech
- Mar 26, 2021Pitango Healthtech first filed Form ADV (ERA, venture capital fund adviser exemption)First SEC adviser filingOrganizationFactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 26, 2021Pitango Healthtech Fund I, L.P. first reported on Form ADV by Pitango Healthtech (Venture Capital Fund), GAV $135,350,000Fund first reported on Form ADVFundsFactPitango Healthtech Fund I, L.P.SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 26, 2021Pitango Healthtech Principals Fund I, L.P. first reported on Form ADV by Pitango Healthtech (Venture Capital Fund), GAV $3,010,500Fund first reported on Form ADVFundsFactPitango Healthtech Principals Fund I, L.P.SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Classification history
- Sep 12, 2026Institutional venture firm (probable, 80%, cls-1)venture manager, reported GAV $143M across 2 vehicles
Evidence
18 observations from 1 source